RSV clinical trial for pregnant women

RSV clinical trial for pregnant women

Mater Research unit is conducting a clinical trial in third trimester for pregnant women at Mater Mothers’ Hospital. 

RSV, or respiratory syncytial virus, is a virus that infects the lungs and breathing passages. Almost every infant is exposed to RSV by the age of 2 years old.  RSV infection can lead to serious complications like pneumonia and may require hospitalisation, particularly in young or premature babies.

There is currently no vaccine available to prevent RSV infections.

A clinical trial is being conducted at the Mater Mothers’ Hospital as part of a large international study. The study will determine whether an investigational RSV vaccine, given to pregnant women during the third trimester of pregnancy, can protect newborn babies from RSV infections.

Vaccines are provided free of charge. A voucher will be provided at each clinic visit for travel expenses.

To register your interest, or for more information, please contact the Mothers’ & Babies Research Unit on 07 3163 8543 or email: MBWHResearch@mater.org.au

Was this information helpful?

Personal
Was this helpful?
 Security code